Peter Georgantopoulos - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Peter Georgantopoulos

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Cancer Journal (Sudbury, Mass.)|September 26, 2025

Cancer Drugs and United States Tariffs: Attention Must Be PaidMaxwell L Izen, June M McKoy, Linda Martin, et al.

Plos One|September 25, 2024

A SONAR report on Nirmatrelvir/ritonavir-associated rebound COVID-19: Using new databases for evaluating new diseasesCharles L Bennett, Joseph Magagnoli, Krishna Gundabolu, et al.

Cancer Medicine|June 22, 2017

Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)Rachel A Sabol, Virginia Noxon, Oliver Sartor, et al.

The Lancet. Oncology|November 8, 2016

Generic oncology drugs: are they all safe?Y Tony Yang, Sumimasa Nagai, Brian K Chen, et al.

The Lancet. Oncology|December 3, 2014

Regulatory and clinical considerations for biosimilar oncology drugsCharles L Bennett, Brian Chen, Terhi Hermanson, et al.

The Journal of Community and Supportive Oncology|March 9, 2016

Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social networkKamaljeet Kaur, Raja Fayad, Arpit Saxena, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Cancer Journal (Sudbury, Mass.)|September 26, 2025

Cancer Drugs and United States Tariffs: Attention Must Be PaidMaxwell L Izen, June M McKoy, Linda Martin, et al.

Plos One|September 25, 2024

A SONAR report on Nirmatrelvir/ritonavir-associated rebound COVID-19: Using new databases for evaluating new diseasesCharles L Bennett, Joseph Magagnoli, Krishna Gundabolu, et al.

Cancer Medicine|June 22, 2017

Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)Rachel A Sabol, Virginia Noxon, Oliver Sartor, et al.

The Lancet. Oncology|November 8, 2016

Generic oncology drugs: are they all safe?Y Tony Yang, Sumimasa Nagai, Brian K Chen, et al.

The Lancet. Oncology|December 3, 2014

Regulatory and clinical considerations for biosimilar oncology drugsCharles L Bennett, Brian Chen, Terhi Hermanson, et al.

The Journal of Community and Supportive Oncology|March 9, 2016

Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social networkKamaljeet Kaur, Raja Fayad, Arpit Saxena, et al.

Pageof 2